Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Leishmania braziliensis-endemic area

Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Leishmania braziliensis-endemic area

BackgroundPentavalent antimonials (PAs) are the primary therapeutic option for American tegumentary leishmaniasis (ATL). However, the use of these drugs is complicated by adverse events (AEs), resistance and contraindications. Alternative therapies relative effectiveness is not well established.Obje...

Full description

Bibliographic Details
Main Authors: Daniel Holanda Barroso, Renata Trindade Gonçalves, Joadyson Silva Barbosa, Jorgeth de Oliveira Carneiro da Motta, Gustavo Subtil Magalhães Freire, Ciro Martins Gomes, Raimunda Nonata Ribeiro Sampaio
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
therapy
liposomal amphotericin B (LAB)
N-methyl glucamine antimoniate
adverse effect
American cutaneous leishmaniasis (ACL)
mucosal leishmaniasis
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.993338/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2022.993338/full

Similar Items